| Titolo |
Pubblicato in |
Anno |
| Epicardial fat and liver stiffness by ARFI elastography in people living with Human Immunodeficiency Virus type 1 (HIV-1) infection without liver disease |
AIDS |
2024 |
| Immune reconstitution and safe metabolic profile after the switch to bictegravir/emtricitabine/tenofovir alafenamide fumarate among virologically controlled plwh. A 96 week update from the bictel cohort |
VIRUSES |
2023 |
| The Many Faces of Immune Activation in HIV-1 Infection. A Multifactorial Interconnection |
BIOMEDICINES |
2023 |
| GRAd-COV2 vaccine provides potent and durable humoral and cellular immunity to SARS-CoV-2 in randomized placebo-controlled phase 2 trial |
CELL REPORTS MEDICINE |
2023 |
| MicroRNA Expression Levels in Peripheral Blood Mononuclear Cells from Human Immunodeficiency Virus Type 1 Positive Individuals and Relationship with Different Levels of Viral Suppression |
AIDS RESEARCH AND HUMAN RETROVIRUSES |
2023 |
| Long-term subjective and objective assessment of smell and taste in COVID-19 |
CELLS |
2022 |
| Antibody response to BNT162b2 SARS-CoV-2 mRNA vaccine in adult patients with systemic sclerosis |
CLINICAL RHEUMATOLOGY |
2022 |
| The Effect of SARS-CoV-2 Vaccination on B-Cell Phenotype in Systemic Sclerosis Patients |
JOURNAL OF PERSONALIZED MEDICINE |
2022 |
| The Effect of SARS-CoV-2 Vaccination on B-Cell Phenotype in Systemic Sclerosis Patients |
JOURNAL OF PERSONALIZED MEDICINE |
2022 |
| Humoral and T-cell mediated response after administration of mRNA vaccine BNT162b2 in frail populations |
VACCINE. X |
2022 |
| Clinical management of patients with primary immunodeficiencies during the COVID-19 pandemic |
EXPERT REVIEW OF CLINICAL IMMUNOLOGY |
2021 |
| Lipopolysaccharide induces platelet activation in HIV patients: the role of different viral load patterns |
HIV MEDICINE |
2021 |
| Arterial and venous thrombosis in coronavirus 2019 disease (Covid-19): relationship with mortality |
INTERNAL AND EMERGENCY MEDICINE |
2021 |
| Switching to a bictegravir single tablet regimen in elderly people living with HIV-1. Data analysis from the BICTEL Cohort |
DIAGNOSTICS |
2021 |
| Dolutegravir-Based Regimen for Maintenance of Viral Suppression in People Living with HIV: 48-Week Results in Real-Life Setting |
AIDS RESEARCH AND HUMAN RETROVIRUSES |
2021 |
| TRANSMITTED DRUG RESISTANCE MUTATIONS AND TRENDS OF HIV-1 SUBTYPES IN TREATMENT-NAÏVE PATIENTS: A SINGLE CENTER EXPERIENCE |
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE |
2020 |
| A case of acanthosis nigricans in a HIV-infected patient |
BMC INFECTIOUS DISEASES |
2020 |
| A possible role for B cells in COVID-19? Lesson from patients with agammaglobulinemia |
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY |
2020 |
| Real word outcomes associated with use of raltegravir in older people living with HIV: results from the 60 months follow-up of the RAL-age cohort |
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY |
2020 |
| Glecaprevir/pibrentasvir ultra-short treatment to cure HCV infection: case report and literature review |
LE INFEZIONI IN MEDICINA |
2020 |
